Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...

The EU-funded project AIDPATH, a collaboration between twelve partners from seven countries, is aiming to increase patient’s access to CAR-T cell therapy, a promising treatment for blood cancers such ...

All these steps are done in well-mixed bioreactors, ... Building Bridges to Scalable Allogeneic Cell Therapy. News-Medical, viewed 08 July 2025, https: ...

Emiri Nakamura and Professor Koji Eto (Department of Clinical Application) has identified microtubule (MT) destabilization as ...

Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double-blind, Randomized, Split-face Study. Acta dermato ...

The firm will use the funds to conduct a Phase I/II trial of an adoptive cell therapy designed to activate T regulatory cells against cancer.

According to Future Market Insights, the global market for portable bioprocessing bioreactors is projected to soar to over ...

Cellares grows in NJ and globally with Smart Factories and key partnerships to advance scalable, cost-effective cell therapy ...

Recently, this limitation has been overcome by a breakthrough treatment that helps the immune system fight cancer more effectively. This therapy involves extracting a patient's own T cells—the ...

Over the last 15 years, I have witnessed how cell and gene therapy (CGT) has evolved in many ways, spanning from research and development to manufacturing. Breakthroughs such as CAR-T and gene ...